Market Cap | 48.06B | P/E | 60.34 | EPS this Y | 18.60% | Ern Qtrly Grth | 135.30% |
Income | 2.71B | Forward P/E | 6.82 | EPS next Y | 13.20% | 50D Avg Chg | 11.00% |
Sales | 68.77B | PEG | 0.83 | EPS past 5Y | 5.83% | 200D Avg Chg | -3.00% |
Dividend | 2.00% | Price/Book | 1.81 | EPS next 5Y | 11.50% | 52W High Chg | -19.00% |
Recommedations | 2.00 | Quick Ratio | 1.29 | Shares Outstanding | 700.32M | 52W Low Chg | 28.00% |
Insider Own | 16.46% | ROA | 0.42% | Shares Float | 584.12M | Beta | 1.03 |
Inst Own | 76.03% | ROE | 10.12% | Shares Shorted/Prior | 7.55M/6.96M | Price | 62.75 |
Gross Margin | 23.83% | Profit Margin | 4.23% | Avg. Volume | 5,526,677 | Target Price | 87.11 |
Oper. Margin | 7.17% | Earnings Date | Oct 30 | Volume | 6,333,634 | Change | -0.11% |
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was incorporated in 1999 and is based in New York, New York.
Jefferies | Buy | Sep 27, 24 |
Barclays | Overweight | Sep 4, 24 |
Morgan Stanley | Overweight | Aug 19, 24 |
Wells Fargo | Overweight | Aug 12, 24 |
B of A Securities | Buy | Aug 1, 24 |
Citigroup | Buy | Jul 23, 24 |
Jefferies | Buy | Jul 18, 24 |
Morgan Stanley | Overweight | Jul 10, 24 |
Keefe, Bruyette & Woods | Outperform | Jul 8, 24 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Johnson Jeh C. | Director Director | May 19 | Buy | 51.69 | 17 | 879 | 2,526 | 12/18/23 |
HUBBARD ROBERT GLENN | Director Director | May 06 | Sell | 72.24 | 6 | 433 | 85,213 | 04/19/23 |
HUBBARD ROBERT GLENN | Director Director | May 06 | Buy | 67.44 | 132 | 8,902 | 85,219 | 04/19/23 |
PODLOGAR SUSAN M | EVP & Chief HR Offic.. EVP & Chief HR Officer | Dec 20 | Sell | 71.91 | 3,000 | 215,730 | 46,193 | 12/22/22 |
DEBEL MARLENE | EVP & Chief Risk Off.. EVP & Chief Risk Officer | Aug 19 | Option | 31.15 | 5,513 | 171,730 | 59,359 | 08/23/22 |
DEBEL MARLENE | EVP & Chief Risk Off.. EVP & Chief Risk Officer | Aug 19 | Sell | 67.6 | 4,060 | 274,456 | 55,299 | 08/23/22 |
Goulart Steven J | EVP & Chief Investme.. EVP & Chief Investment Officer | Feb 08 | Option | 34.21 | 78,691 | 2,692,019 | 272,233 | 02/10/22 |
Goulart Steven J | EVP & Chief Investme.. EVP & Chief Investment Officer | Feb 08 | Sell | 70.29 | 56,857 | 3,996,479 | 215,376 | 02/10/22 |
SCHMIDT OSCAR | President, Latin Ame.. President, Latin America | Dec 28 | Option | 34.21 | 11,416 | 390,541 | 12,839 | 12/28/20 |
Khalaf Michel | President & CEO President & CEO | Dec 21 | Option | 40.91 | 29,383 | 1,202,059 | 60,565 | 12/21/20 |